SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 232 filers reported holding SAGE THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.89 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $2,246,000 | +20.3% | 30,000 | -53.8% | 0.53% | +6.7% |
| Q1 2020 | $1,867,000 | -82.8% | 65,000 | -56.7% | 0.50% | -76.0% |
| Q4 2019 | $10,829,000 | -29.8% | 150,000 | +36.4% | 2.06% | -47.6% |
| Q3 2019 | $15,432,000 | +180.9% | 110,000 | +266.7% | 3.93% | +245.2% |
| Q2 2019 | $5,493,000 | -54.0% | 30,000 | -60.0% | 1.14% | -63.5% |
| Q1 2019 | $11,929,000 | +273.9% | 75,000 | +125.2% | 3.12% | +169.2% |
| Q4 2018 | $3,190,000 | +137.7% | 33,300 | +250.5% | 1.16% | +306.3% |
| Q3 2018 | $1,342,000 | -24.9% | 9,500 | -14.4% | 0.28% | -21.3% |
| Q1 2018 | $1,788,000 | -83.4% | 11,100 | -83.0% | 0.36% | -85.6% |
| Q4 2017 | $10,745,000 | +15.0% | 65,237 | -56.5% | 2.52% | +27.0% |
| Q3 2017 | $9,345,000 | +134.7% | 150,000 | +200.0% | 1.98% | +139.6% |
| Q2 2017 | $3,982,000 | -44.0% | 50,000 | -50.0% | 0.83% | -37.5% |
| Q1 2017 | $7,107,000 | -30.4% | 100,000 | -50.0% | 1.32% | -46.1% |
| Q4 2016 | $10,212,000 | +26.7% | 200,000 | +14.3% | 2.46% | +88.1% |
| Q3 2016 | $8,059,000 | +78.3% | 175,000 | +16.7% | 1.31% | +0.2% |
| Q2 2016 | $4,520,000 | -11.9% | 150,000 | -6.2% | 1.30% | -55.0% |
| Q1 2016 | $5,130,000 | -56.0% | 160,000 | -20.0% | 2.90% | -39.2% |
| Q4 2015 | $11,660,000 | +575.2% | 200,000 | +390.2% | 4.77% | +514.4% |
| Q3 2015 | $1,727,000 | -73.5% | 40,800 | -54.3% | 0.78% | -63.2% |
| Q2 2015 | $6,512,000 | -46.0% | 89,200 | -62.8% | 2.11% | -2.7% |
| Q1 2015 | $12,056,000 | – | 240,000 | – | 2.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,966,688 | $120,204,000 | 10.81% |
| Integral Health Asset Management, LLC | 230,000 | $14,058,000 | 4.30% |
| Asymmetry Capital Management, L.P. | 102,462 | $6,262,000 | 4.02% |
| ACUTA CAPITAL PARTNERS, LLC | 225,000 | $13,752,000 | 3.74% |
| DAFNA Capital Management LLC | 158,306 | $9,676,000 | 3.14% |
| Bain Capital Life Sciences Investors, LLC | 499,100 | $30,505,000 | 2.84% |
| Boxer Capital, LLC | 1,094,000 | $66,865,000 | 2.31% |
| Palo Alto Investors LP | 590,200 | $36,073,000 | 1.98% |
| Logos Global Management LP | 250,000 | $15,280,000 | 1.96% |
| Bellevue Group AG | 1,579,504 | $96,539,000 | 1.33% |